|
|
||||||||
Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261
To achieve efficient systemic gene delivery to the lung
with minimal toxicity, a vector was developed by chemically conjugating a cationic polymer, polyethylenimine (PEI), with anti-platelet endothelial cell adhesion molecule (PECAM) antibody (Ab). Transfection of mouse lung endothelial cells with a plasmid expression vector with
cDNA to luciferase (pCMVL) complexed with anti-PECAM Ab-PEI conjugate
was more efficient than that with PEI-pCMVL complexes. Furthermore, the
anti-PECAM Ab-PEI conjugate mediated efficient transfection at lower
charge plus-to-minus ratios. Conjugation of PEI with a
control IgG (hamster IgG) did not enhance transfection of mouse lung
endothelial cells, suggesting that the cellular uptake of anti-PECAM
Ab-PEI-DNA complexes and subsequent gene expression were governed by a
receptor-mediated process rather than by a nonspecific charge
interaction. Conjugation of PEI with anti-PECAM Ab also led to
significant improvement in lung gene transfer to intact mice after
intravenous administration. The increase in lung transfection was
associated with a decrease compared with PEI-pCMVL with respect to
circulating proinflammatory cytokine (tumor necrosis factor-
)
levels. These results indicate that targeted gene delivery
to the lung endothelium is an effective strategy to enhance gene
delivery to the pulmonary circulation while simultaneously reducing toxicity.
cationic polymer; plasmid deoxyribonucleic acid; gene transfer; targeting; toxicity
This article has been cited by other articles:
![]() |
M. Christofidou-Solomidou, A. Scherpereel, R. Wiewrodt, K. Ng, T. Sweitzer, E. Arguiri, V. Shuvaev, C. C. Solomides, S. M. Albelda, and V. R. Muzykantov PECAM-directed delivery of catalase to endothelium protects against pulmonary vascular oxidative stress Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L283 - L292. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Muro, R. Wiewrodt, A. Thomas, L. Koniaris, S. M. Albelda, V. R. Muzykantov, and M. Koval A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1 J. Cell Sci., April 15, 2003; 116(8): 1599 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ma, J. Zhang, S. Alber, J. Dileo, Y. Negishi, D. Stolz, S. Watkins, L. Huang, B. Pitt, and S. Li Lipid-Mediated Delivery of Oligonucleotide to Pulmonary Endothelium Am. J. Respir. Cell Mol. Biol., August 1, 2002; 27(2): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Scherpereel, J. J. Rome, R. Wiewrodt, S. C. Watkins, D. W. Harshaw, S. Alder, M. Christofidou-Solomidou, E. Haut, J.-C. Murciano, M. Nakada, et al. Platelet-Endothelial Cell Adhesion Molecule-1-Directed Immunotargeting to Cardiopulmonary Vasculature J. Pharmacol. Exp. Ther., March 1, 2002; 300(3): 777 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wiewrodt, A. P. Thomas, L. Cipelletti, M. Christofidou-Solomidou, D. A. Weitz, S. I. Feinstein, D. Schaffer, S. M. Albelda, M. Koval, and V. R. Muzykantov Size-dependent intracellular immunotargeting of therapeutic cargoes into endothelial cells Blood, February 1, 2002; 99(3): 912 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. MURCIANO, D. WIN HARSHAW, L. GHITESCU, S. M. DANILOV, and V. R. MUZYKANTOV Vascular Immunotargeting to Endothelial Surface in a Specific Macrodomain in Alveolar Capillaries Am. J. Respir. Crit. Care Med., October 1, 2001; 164(7): 1295 - 1302. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Danilov, V. D. Gavrilyuk, F. E. Franke, K. Pauls, D. W. Harshaw, T. D. McDonald, D. J. Miletich, and V. R. Muzykantov Lung uptake of antibodies to endothelial antigens: key determinants of vascular immunotargeting Am J Physiol Lung Cell Mol Physiol, June 1, 2001; 280(6): L1335 - L1347. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |